Table 1.

Patient Characteristics

Variable	Methylphenidate Group (n=10)	Placebo Group (n = 13)	Total (n=23)
Mean Age	68±8	71±10	70±9
Race
-Caucasian	10 (100%)	12 (92%)	22 (96%)
-African-American	--	1 (8%)	1 (4%)
Marital Status
-Married	6 (60%)	11 (85%)	17 (74%)
-Single	2 (20%)	1 (8%)	3 (13%)
-Divorced/Separated	2 (20%)	1 (8%)	3 (13%)
Baseline BFI Score
-Total Scores	5.13 (2.25)	4.01 (2.00)	4.54 (2.13)
-Severity Subscale	6.50 (2.09)	5.74 (2.05)	6.07 (2.05)
-Interference Subscale	4.45 (2.56)	3.26 (2.30)	3.78 (2.43)
Baseline FSS
-Mean Score	4.27 (1.31)	4.27 (1.37)	4.27 (1.32)

Note: No significant differences between the Methylphenidate group and the placebo group.